Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Nice Insight offers a unique perspective by tracking critical data relating
to the pharmaceutical CRO/CMO marketplace. The data they garner, as well as
their overall approach, puts them in a leading position for market
research."
Jeff Reinke editorial director, Pharmaceutical Processing & Manufacturing.net  
DIA 2013 49th Annual Meeting
June 23-27 Boston, MA |
Anteco Pharma LLC Boehringer Ingelheim GmbH Cirrus Pharmaceuticals Corealis Pharma, Inc. CoreRx, Inc. Dr. Reddy's Laboratories Ltd. Aptalis Pharmaceutical Technologies Piramal Healthcare Pharma Solutions Recipharm AB Xcelience LLC Galenix Inc.
Galenix Inc. provides a range of services for each stage of the pharmaceutical development process from preformulation, analytical and formulation development through clinical trial supplies for phase I, II and III and to scale-up and high volume pilot production. A division of the company, Galenix Innovations, focuses on drug delivery solutions for life cycle management, new chemical entities using conventional dosage forms or its own patented technologies. To date, the company has patented six innovative drug delivery systems. http://www.galenix.fr
Regions
Americas, Europe Stock Symbol Private Filter of Galenix Inc.'s services per Nice Insight Categories
Contact Galenix Inc. 
|
|
|
